Comparative analysis of biochemical and genomic approaches to newborn screening for lysosomal storage disorders in a Chinese cohort

Lysosomal storage disorders (LSDs) are severe inherited metabolic diseases for which early diagnosis through newborn screening (NBS) enables timely initiation of disease specific therapies and improves long term outcomes. However, the comparative performance of biochemical screening, genetic screening, and their combination in Chinese populations remains poorly characterized. This prospective, real-world implementation study was conducted at Jinan Maternity and Child Care Hospital between May 2023 and June 2026. A total of 6204 newborns were allocated to three screening strategies based on parental preference: only biochemical screening (NBS, n = 2581), only newborn genetic screening (NBGS, n = 3193), and combined screening (n = 430). Positive predictive value (PPV), disease specific performance, carrier frequency, and minor allele frequency (MAF) were analyzed. NBS identified 27 initial screen positive cases (0.90%), 5 remained positive on repeat testing, of which 2 were confirmed (1 Fabry disease, 1 Krabbe disease), yielding an overall PPV of 7.4% at initial screening. NBGS identified 2 confirmed cases (1 Fabry, 1 Krabbe). Combined screening identified 1 Fabry case. Carrier frequency analysis revealed that 3.78% carried at least one pathogenic or likely pathogenic variant. GALC c.1901T > C (1.71%), GALC c.2041G > A (0.69%), and GAA c.761 C > T (0.19%) accounted for 68.6% of all carriers. MAF comparison with ExAC-EAS showed enrichment of GALC c.2041G > A in the northern Chinese population, suggesting a regional founder effect. Biochemical screening for LSDs achieves high sensitivity but is limited by low specificity. Genetic screening offers superior specificity but requires enzymatic confirmation for clinical actionability. The combined strategy effectively provides a high diagnostic accuracy while reducing false positive recalls. Population specific carrier frequency and MAF data from this study provide essential reference information for designing LSD screening programs in Chinese populations.

Authors

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-81374-4
Primary Topic
Lysosomal Storage Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparative analysis of biochemical and genomic approaches to newborn screening for lysosomal storage disorders in a Chinese cohort

Hui Zou, Jialin Mu
Scientific Reports
Lysosomal Storage Disorders Research
article

Comparative analysis of biochemical and genomic approaches to newborn screening for lysosomal storage disorders in a Chinese cohort

Hui Zou, Jialin Mu
article en

Abstract

Lysosomal storage disorders (LSDs) are severe inherited metabolic diseases for which early diagnosis through newborn screening (NBS) enables timely initiation of disease specific therapies and improves long term outcomes. However, the comparative performance of biochemical screening, genetic screening, and their combination in Chinese populations remains poorly characterized. This prospective, real-world implementation study was conducted at Jinan Maternity and Child Care Hospital between May 2023 and June 2026. A total of 6204 newborns were allocated to three screening strategies based on parental preference: only biochemical screening (NBS, n = 2581), only newborn genetic screening (NBGS, n = 3193), and combined screening (n = 430). Positive predictive value (PPV), disease specific performance, carrier frequency, and minor allele frequency (MAF) were analyzed. NBS identified 27 initial screen positive cases (0.90%), 5 remained positive on repeat testing, of which 2 were confirmed (1 Fabry disease, 1 Krabbe disease), yielding an overall PPV of 7.4% at initial screening. NBGS identified 2 confirmed cases (1 Fabry, 1 Krabbe). Combined screening identified 1 Fabry case. Carrier frequency analysis revealed that 3.78% carried at least one pathogenic or likely pathogenic variant. GALC c.1901T > C (1.71%), GALC c.2041G > A (0.69%), and GAA c.761 C > T (0.19%) accounted for 68.6% of all carriers. MAF comparison with ExAC-EAS showed enrichment of GALC c.2041G > A in the northern Chinese population, suggesting a regional founder effect. Biochemical screening for LSDs achieves high sensitivity but is limited by low specificity. Genetic screening offers superior specificity but requires enzymatic confirmation for clinical actionability. The combined strategy effectively provides a high diagnostic accuracy while reducing false positive recalls. Population specific carrier frequency and MAF data from this study provide essential reference information for designing LSD screening programs in Chinese populations.

Scientific Reports
Lysosomal Storage Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon